Changeflow GovPing

What do you monitor?

Curated feeds for your role. Pick your area and get exactly the sources you need.

Recent changes

Favicon for changeflow.com

Medical Tube Holder Patent Application

European Patent Office published patent application EP3459583A1 for a medical tube holder invented by Se Hee HER and assigned to applicant Smhers. The patent is classified under IPC A61M 25/01 and A61M 25/00, covering medical tube securing devices. The application designates 39 European member states including all major EU markets.

Routine Notice Healthcare
Favicon for changeflow.com

Connector System for Releasably Connecting Fluid Conduits

The European Patent Office published patent EP3405714A1 for WilMarc Holdings, LLC covering a connector system for releasably connecting fluid conduits in medical applications. The patent was published March 25, 2026, with inventors CICCONE, Paul C., COULSON, William A., and COULSON, Marcia. Designated states include most EU member states and EPO contracting states.

Routine Notice Healthcare
Favicon for changeflow.com

Medical Delivery System Patent

The European Patent Office published patent EP3448466A1 for Koska Family Ltd., covering a medical delivery system. The patent application was filed by inventors Marc Andrew Koska and others, with international patent classification A61M covering medical devices for delivery/administration. The patent is published in all designated European Patent Convention states.

Routine Notice Medical Devices
Favicon for changeflow.com

Safety Syringe Apparatus Patent

The European Patent Office published Owen Mumford Limited's safety syringe apparatus patent application EP3405239A1, classified under IPC A61M 5/32. The patent application covers medical device technology for safety syringes and was filed by inventor Damian Alexander Holland. No compliance obligations are created by this patent publication notice.

Routine Notice Healthcare
Favicon for changeflow.com

Automatic Relay Pump System Patent

The European Patent Office published patent application EP3308812A2 for an Automatic Relay Pump System filed by CareFusion 303, Inc. (inventor: Pierre Rebours). The A2 publication indicates the application has entered the European regional phase and is available for opposition. The patent covers a relay pump system classified under IPC A61M for medical applications.

Routine Notice Medical Devices
Favicon for changeflow.com

Mallinckrodt patent EP3108241A1 compensates gas sensor drift

Mallinckrodt patent EP3108241A1 compensates gas sensor drift

Routine Notice
Favicon for changeflow.com

Spermidine and High Protein Composition for Autophagy Induction

European Patent Office published Patent EP3727419A1 by Société des Produits Nestlé S.A. covering a composition combining spermidine with high protein for induction of autophagy. The patent application was filed June 28, 2019 and designates all 35 EPO member states and extension states. Inventors include Gabriele Civiletto, Bernard Cuenoud, Jerome Feige, and Philipp Gut.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

Antisense Molecules and Methods for Treating Pathologies

The European Patent Office published patent application EP3431603A1 filed by the University of Western Australia on March 25, 2026. The application covers antisense molecules and methods for treating pathologies, with inventors including Stephen Wilton, Sue Fletcher, Abbie Adams, and Penny Meloni. Upon grant, the patent will provide intellectual property protection for the claimed antisense compositions and therapeutic methods across designated European member states.

Routine Notice Intellectual Property
Favicon for changeflow.com

Nanoparticle Comprising Rapamycin and Albumin as Anticancer Agent

The European Patent Office published patent application EP3417859A1 for Abraxis BioScience, LLC covering a nanoparticle composition comprising rapamycin and albumin for anticancer applications. The patent application, filed by inventors Neil P. Desai, Patrick Soon-Shiong, and Vuong Trieu, has been published as an A1 document (first publication with search report). The patent is directed to designated states across the European Patent Convention member states including AT, BE, DE, FR, GB, IT, NL, and others.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

Treatment of Cancer Using Doxorubicin and Attenuated Salmonella Typhimurium Encoding IL-2

The European Patent Office published patent EP3550976A1 for Salspera LLC, covering a cancer treatment combining doxorubicin (≤1.25 mg/kg) with attenuated Salmonella typhimurium containing a plasmid encoding human interleukin-2. The patent names Daniel A. Saltzman as inventor and designates all EU member states plus several additional European countries.

Routine Notice Healthcare

Showing 5661–5670 of 39,815 changes

1 565 566 567 568 569 3982

Get alerts when regulations change

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.